Last updated: September 26, 2022
Sponsor: Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Overall Status: Active - Enrolling
Phase
N/A
Condition
Cancer/tumors
Breast Cancer
Carcinoma
Treatment
N/AClinical Study ID
NCT05558917
ASO.RianGen.22.02
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients undergoing mastectomy exclusively for breast cancer
- Presence of written informed consent to the trial
Exclusion
Exclusion Criteria:
- Bilateral breast surgery
- Previous drug use
- Chronic opioid and minor opioid therapy
- BMI >40
- Allergy or contraindications to taking Paracetamol and Toradol
- Inability to use PCA (Patient Controlled Analgesia)
- Intraoperative opioid administration
- Patients with neuropathy
Study Design
Total Participants: 160
Study Start date:
September 07, 2022
Estimated Completion Date:
November 07, 2023
Study Description
Connect with a study center
Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo
Alessandria, Piedmont 15121
ItalySite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.